$AZN
AI分析生成日 May 11, 2026
AI Score
Buy$AZN
AstraZeneca PLC
$AZNNASDAQHealthcareMega-Cap
AstraZeneca develops prescription medicines in oncology, cardiovascular, renal, respiratory, and immunology.
Market Cap
$220.0B
Revenue (TTM)
$49.0B
+8.0%
Net Income (TTM)
$6.5B
+12.0%
EPS (TTM)
$4.20
P/E Ratio
35.0
Dividend Yield
2.0%
52-Week Range
$58-$87
Beta
0.52
Dimension Scores
Fundamental
78Technical
68Sentiment
74Risk / Reward
76Momentum
68Financial Health
Profitability
83strong
Growth
71moderate
Liquidity
84strong
Solvency
80strong
Efficiency
76strong
Valuation, technical analysis, investment thesis, risk assessment and more for $AZN
Free · No credit card required
免責事項: AI生成の分析は教育目的のみです。投資アドバイスではありません。必ず資格のあるファイナンシャルアドバイザーにご相談ください。